From planning to patency: optimizing AV access maturation, cannulation and intervention

This PVI 2025 session provides a comprehensive look at arteriovenous (AV) access management, covering strategies to maximise maturation, usability, and long-term patency. Experts share evidence-based insights from trials and real-world experiences, including the VENOS-2 trial, demonstrating that percutaneous AVFs remain a viable option.

The session explores site selection and positioning for cannulation success, optimising AVF maturation, and knowing when to intervene or utilise devices. Practical case discussions, including the Kinetic Endovascular Micro-Incision Creation (KEMIC) technique, illustrate procedural strategies, clinical outcomes, and potential economic benefits from both U.S. and European perspectives.

Gain a clear framework to promote AVF maturation, apply best practices for access positioning, and make timely clinical decisions to ensure long-term success, and learn how to translate planning into patency for every AV access patient.